Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency.
暂无分享,去创建一个
J. Drai | J. Orgiazzi | Jocelyne Drai | Jacques Orgiazzi | Ilham Seghrouchni | Edith Bannier | Joël Rivière | Pascale Calmard | Isabelle Garcia | André Revol | A. Revol | I. Seghrouchni | E. Bannier | I. Garcia | P. Calmard | J. Rivière
[1] M. Pirisi,et al. Total Plasma Antioxidant Capacity Predicts Thrombosis-Prone Status in NIDDM Patients , 1997, Diabetes Care.
[2] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[3] P. Frost,et al. Simultaneous determination of vitamins A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects. , 1993, Clinical chemistry.
[4] F. Ulberth,et al. Nutritional Antioxidants, Red Cell Membrane Fluidity and Blood Viscosity in Type 1 (insulin dependent) Diabetes Mellitus , 1996 .
[5] A. Meister. Methods for the selective modification of glutathione metabolism and study of glutathione transport. , 1985, Methods in enzymology.
[6] A. Alegría,et al. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. , 1999, Scandinavian journal of clinical and laboratory investigation.
[7] G. Paolisso,et al. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? , 1995, Metabolism: clinical and experimental.
[8] S. Arimori,et al. Increased Superoxide Production by Mononuclear Cells of Patients With Hypertriglyceridemia and Diabetes , 1988, Diabetes.
[9] G. Paolisso,et al. Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.
[10] U. Das,et al. OXIDANT STRESS, ANTI-OXIDANTS AND NITRIC OXIDE IN NON-INSULIN DEPENDENT DIABETES MELLITUS , 1997 .
[11] T. Lyons. Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[12] J. Škrha,et al. Plasma Malondialdehyde and Obesity: Is there a Relationship? , 1999, Clinical chemistry and laboratory medicine.
[13] A. Griesmacher,et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. , 1995, The American journal of medicine.
[14] K. Hughes,et al. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. , 1998, Atherosclerosis.
[15] W. Valentine,et al. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.
[16] P. Guillausseau,et al. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[17] Y. Sun,et al. A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.
[18] D. Hayoz,et al. Diabetes mellitus and vascular lesions. , 1998, Metabolism: clinical and experimental.
[19] L. Poston,et al. Oxidative Stress and Lipids in Diabetes: A Role in Endothelium Vasodilator Dysfunction? , 1996, Vascular Medicine.
[20] G. Steiner,et al. Atherosclerosis, the major complication of diabetes. , 1985, Advances in experimental medicine and biology.
[21] S. Jain,et al. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. , 1994, Metabolism: clinical and experimental.
[22] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[23] Hans Ulrich Bergmeyer,et al. Methods of Enzymatic Analysis , 2019 .
[24] M. Gussinyé,et al. Oxidative Stress at Onset and in Early Stages of Type 1 Diabetes in Children and Adolescents , 1998, Diabetes Care.
[25] L. Oberley. Free radicals and diabetes. , 1988, Free radical biology & medicine.
[26] B. Halliwell,et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM , 1997, Diabetologia.
[27] C. Rice-Evans,et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. , 1993, Clinical science.
[28] A. Lee,et al. Contributions of polyol pathway to oxidative stress in diabetic cataract , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Daniel L. McGee,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[30] A. Favier,et al. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. , 1992, Clinical chemistry.
[31] V. Mohan,et al. Does oxidant stress play a role in diabetic retinopathy? , 1995, Indian journal of ophthalmology.